---
figid: PMC12068849__ijo-66-05-05742-g01
figtitle: Wnt/Beta-catenin pathway activation and inhibition
organisms:
- NA
organisms_ner:
- Homo sapiens
- Danio rerio
pmcid: PMC12068849
filename: ijo-66-05-05742-g01.jpg
figlink: /pmc/articles/PMC12068849/figure/F2/
number: F2
caption: Wnt/β-catenin pathway activation and inhibition. Activation of the Wnt signaling
  pathway leads to the formation of the Wnt-FZD-LRP complex, which suppresses GSK-3β
  activity, preventing normal phosphorylation of β-catenin and subsequent binding
  with TCF/LEF transcription factors in the nucleus to activate downstream target
  genes. Inhibition of the Wnt signaling pathway results in normal degradation of
  β-catenin, precluding its entry into the nucleus for transcription. TCF/LEF, T cell
  factor/lymphoid enhancer-binding factor; LRP, lipoprotein receptor-related protein;
  GSK-3β, glycogen synthase kinase-3β; FZD, frizzled; APC, adenomatous polyposis coli;
  CK1, casein kinase 1; DVL, dishevelled
papertitle: Role of the Wnt signaling pathway in the complex microenvironment of breast
  cancer and prospects for therapeutic potential (Review)
reftext: Meng Xuan Sun, et al. Int J Oncol. 2025 May;66(5).
year: '2025'
doi: 10.3892/ijo.2025.5742
journal_title: International Journal of Oncology
journal_nlm_ta: Int J Oncol
publisher_name: Spandidos Publications
keywords: Wnt signaling pathway | breast cancer | tumor microenvironment | pathway
  crosstalk | targeted therapy
automl_pathway: 0.9678838
figid_alias: PMC12068849__F2
figtype: Figure
redirect_from: /figures/PMC12068849__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC12068849__ijo-66-05-05742-g01.html
  '@type': Dataset
  description: Wnt/β-catenin pathway activation and inhibition. Activation of the
    Wnt signaling pathway leads to the formation of the Wnt-FZD-LRP complex, which
    suppresses GSK-3β activity, preventing normal phosphorylation of β-catenin and
    subsequent binding with TCF/LEF transcription factors in the nucleus to activate
    downstream target genes. Inhibition of the Wnt signaling pathway results in normal
    degradation of β-catenin, precluding its entry into the nucleus for transcription.
    TCF/LEF, T cell factor/lymphoid enhancer-binding factor; LRP, lipoprotein receptor-related
    protein; GSK-3β, glycogen synthase kinase-3β; FZD, frizzled; APC, adenomatous
    polyposis coli; CK1, casein kinase 1; DVL, dishevelled
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - LRP5
  - LRP6
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - FZD1
  - FZD10
  - FZD2
  - FZD3
  - FZD4
  - FZD5
  - FZD6
  - FZD7
  - FZD8
  - FZD9
  - DVL1
  - DVL1P1
  - DVL2
  - DVL3
  - AXIN1
  - AXIN2
  - APC
  - PROC
  - CSNK1A1
  - KRT1
  - CSNK1A1L
  - GSK3A
  - GSK3B
  - CTNNB1
  - PSMA1
  - PSMA2
  - PSMA3
  - PSMA4
  - PSMA5
  - PSMA6
  - PSMA7
  - PSMA8
  - PSMB1
  - PSMB10
  - PSMB2
  - PSMB3
  - PSMB4
  - PSMB5
  - PSMB6
  - PSMB7
  - PSMB8
  - PSMB9
  - PSMC1
  - PSMC2
  - PSMC3
  - PSMC4
  - PSMC5
  - PSMC6
  - PSMD1
  - PSMD10
  - PSMD11
  - PSMD12
  - PSMD13
  - PSMD14
  - PSMD2
  - PSMD3
  - PSMD4
  - PSMD5
  - PSMD6
  - PSMD7
  - PSMD8
  - PSMD9
  - PSME1
  - PSME2
  - PSME3
  - PSMF1
  - SEM1
  - USP5
  - HNF4A
  - ADA
  - ADAD1
  - ADAD2
  - ADAR
  - ADARB1
  - ADARB2
  - ADAT1
  - ADAT2
  - ADAT3
  - lrp5
  - lrp6
  - apc
  - gsk3ba
  - gsk3ab
  - ctnnb1
  - elk4
  - ada
---
